Loading

Daniel Bainbridge, MD, FRCPC

  • Associate Professor
  • Anesthesia and Perioperative Medicine
  • Schulich School of Medicine
  • University of Western Ontario
  • London, Ontario, Canada

Clinical Infectious Diseases spasms by rib cage order mefenamic 250 mg on-line, American Journal of Infection Control 303 muscle relaxant reviews order mefenamic 500 mg mastercard, 1995 muscle relaxant klonopin mefenamic 500mg low cost, handwashing routines on the microbial counts of operating room nurses muscle spasms 6 letters discount mefenamic 250 mg without a prescription. Antimicrobial Agents and Chemotherapy, 1999, Disinfection, sterilization and preservation, 4th the healthcare setting: is there a relationship between germicide use and antibiotic resistance? Infection Control and Hospital Epidemiology healthcare environment: should it be of genuine concern? Journal of Hospital Infection antimicrobial efficiency of surfacine hand sanitizer. Outbreak of Clostridium difficile infection in an Eurosurveillance Clostridium difficile gluconate for the removal of Clostridium difficile from bare hands and gloved hands. Infection Control and Hospital Epidemiology bactericidal efficacy of consecutive surgical hand disinfection with standard alcohols and on skin hydration. American Journal of Medicine, 1990, Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores. Infection Control and Hospital Epidemiology, 2003, incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infection Control and Hospital Epidemiology Clostridium difficileassociated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased Infection Control and Hospital Epidemiology of drug-resistant bacteria after introduction of an alcohol-based handrub. Eurosurveillance Clostridium difficile Emerging Infectious Diseases, 2006, Clostridium difficile Eurosurveillance Clostridium difficile Eurosurveillance, American Journal of Pharmacy used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands. The effect of hand hygiene on illness rate among students in university residence halls. Assessment of handwashing practices with chemical and microbiologic methods: preliminary results from a prospective crossover study. Archives of Pediatric Adolescent Medicine solution versus standard handwashing with antiseptic soap: randomised clinical trial. High-level triclosan resistance in Pseudomonas aeruginosa American Journal of Infection Control Pseudomonas aeruginosa Journal of Bacteriology, 2002, 184:5036­5044. Antimicrobial Agents and Chemotherapy, 2004, resistant Staphylococcus aureus Hospital Infection, 2003, 55:141­144. Antimicrobial Agents and Chemotherapy, 2004, antimicrobial resistance in the hospital environment. Applied Environmental Microbiology, 2006, Archives of Environmental Health with alcohols at various concentrations: parallel experiments in testing a chlorhexidine-containing ethanol-based hand rub can result in a false positive efficacy assessment. Development and evaluation of a new alcohol-based surgical hand scrub formulation with persistent antimicrobial characteristics and brushless application. American Journal of Infection Control, 1998, methicillin-resistant Staphylococcus aureus from contaminated hands. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Journal of Hospital Infection disinfectants against enveloped and non-enveloped viruses. Emerging Infectious Diseases, 2001, using alcohol gel as the skin decontaminant, reduces the costs. Journal of Hospital Infection Klinische Antiseptic compliance with more accessible sinks. Infection Control, Hospital epidemiology and infection control, Prevention of nosocomial infections by location of sinks for hand washing adjacent to the bedside presented at: 33rd Interscience Conference on Antimicrobial isolation rooms on patient care practices, colonization and infection in an intensive care unit. Critical Care hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus infection. Strasbourg, Council contamination of alcohol solutions used in hospital pharmacies in antiseptic preparation manufacturing. European Journal of Hospital Pharmacy sporicide in alcohol disinfectant solutions. Archives of Surgery, 1956, Pseudomonas surgical-site infections linked to a healthcare worker with onychomycosis. Infection Control and Hospital Epidemiology handscrubbing-related surgical site infections in vascular surgical procedures. Zentralblatt fur Gynдkology, 1894, Infection enterococci: a clinical and epidemiologic study. American Journal of Infection Control Surgery, Gynecology & Obstetrics Surgery, Gynecology & Obstetrics, 1969, 129:1181­1184. British Journal of Experimental Pathology Journal of Hдnde-Hygiene im Gesundheitswesen Hospital Infection, 2002, 51:312­315. Association of Operating Room Nurses Journal, infection associated with ungloved abdominal palpation. Journal of Hospital Infection transformation product of the bactericide triclosan, in fish from various lakes in Switzerland. British Journal of Surgery evaluation of surgical scrubbing with disposable iodophorsoap impregnated polyurethane scrub sponges. Surgery, (or routine) hand disinfection is more useful than classic handwashing: in vitro and in vivo studies in burn and other intensive care units. Burns alcohol solution on hand application in newborn and pediatric intensive care units: control of an outbreak of multiresistant Klebsiella pneumoniae in a newborn intensive care unit with this measure. Surgery, Gynecology & Obstetrics, handwashing and use of brush improve the result of surgical hand disinfection? American Journal of Infection Control to alcohol-based hand hygiene solution during prolonged use in a large teaching hospital. New England Journal of Medicine of patient colonization with Stenotrophomonas maltophilia. Infection Control and Hospital Epidemiology efficacy of 3-minute surgical reference disinfection method Applied Environmental Microbiology, 2004, 569. Summary of the multimodal strategy selected gram-positive and gram-negative organisms. Acta Dermatologica Venereologica British Journal of Dermatology, and detergents on skin irritation. Clinical and Experimental Allergy contact dermatitis elicited by povidone-iodine preparations. Journal of Hospital Infection dermatitis from ethyl-2-bromo-p-methoxyphenylacetate. Acta Dermatologica Venereologica effect of in vitro penetration of sodium lauryl sulfate and nickel chloride through human skin. Contact allergies in healthcare workers ­ Acta Dermatologica Venereologica, to isostearyl alcohol in two separate groups of panelists. Swiss Contact Dermatitis Contact Dermatitis Nursing Times prevention of nosocomial infections. Annals of Internal Medicine tolerance in relation to a well-conducted introduction to rub-in hand disinfection. Journal of Hospital Infection, 2001, International Journal of Occupational Medicine and Environmental Health reactions in anaesthetised patients ­ four cases of chlorhexidine allergy. International Journal of Hygiene and Environmental Health introduction and continuation of alcohol-based hand rubs for hygienic hand disinfection. International Archives of Occupational and Environmental Health Heart & Lung, 2003, 32:283­289. Contact Dermatitis randomized trial of scheduled use of a novel barrier cream and an oil-containing lotion for protecting the hands of health care workers. Infection Control decontamination in intensive care units: knowledge, attitudes, and behaviour in Italy. American Journal of Tropical Medicine and Hygiene Klebsiella pneumoniae chlorhexidine. Pseudomonas aeruginosa outbreak in a neonatal intensive care unit: a possible link to contaminated hand lotion. International Archives of Occupational and Environmental Health and occlusive gloves: an experimental study.

cheap 250 mg mefenamic with amex

Other cytokines and lymphokines are inhibited by cyclosporine and the overall effect is a reduction in the number and activity of proinflammatory cells at sites of inflammation spasms headache order 250 mg mefenamic free shipping. Cyclosporine carcinogenesis is attributed in part to its immunosuppressive activity spasms ms mefenamic 500 mg free shipping, resulting in impaired surveillance back spasms 32 weeks pregnant discount mefenamic 250mg on line, particularly for virus-induced cancer muscle relaxant powder generic mefenamic 500mg without a prescription. All adverse effects reported in humans occur under the conditions of the therapeutic doses. The most frequent toxic side effect of 108 cyclosporine is kidney toxicity; of course, the intended effect of therapeutic use (immunosuppression) would also be considered an adverse effect under environmental exposure conditions. The nephrotoxicity observed in humans is supported by several reports of nephrotoxicity in experimental animals. Developmental effects (increased postimplantation loss, decreased weight gain, skeletal retardation) have been observed in rats and rabbits at maternally toxic doses (30 mg/kg-day in rats, and 100 mg/kg-day in rabbits). In a one-generation reproductive toxicity study, no clear evidence of reproductive toxicity was seen at doses up to 14 mg/kg-day (Ryffel et al. However, there was no effect on male fertility in the reproductive toxicity study conducted that resulted in decreased body weight gain in males, and nephrotoxicity in some animals (Ryffel et al. Persons with kidney disease are more susceptible to the adverse renal effects and apparently the immunosuppressive effects of cyclosporine. Postimplantation loss increased at 17 mg/kg-day, but data were presented only on a per pup basis, Males had decreased body weight gain. No clear reproductive effects, although 2 females at 15 mg/kg-day had difficult labor Ryffel et al. Influence of cyclosporine on the occurrence of nephrotoxicity after allogeneic hematopoietic stem cell transplantation: A systematic review. Department of Health and Human Services, Public Health Service, National Toxicology Program. International Commission for Protection Against Environmental Mutagens and Carcinogens. Cyclosporine A: review of genotoxicity and potential for adverse human reproductive and developmental effects. No data were located on the absorption of citrinin via the oral or inhalation routes. The observation of systemic toxicity following oral exposure and excretion via the urinary route indicates that oral absorption occurs, but the data are insufficient to estimate the rate or extent of absorption. In an in vitro human skin model, citrinin was shown to penetrate through the skin (Boonen et al. The elimination from plasma was biphasic, with half-lives of about 2 and 40 hours. However, the cited studies only reported the presence and amount of citrinin in the endemic areas and did not conduct any further analysis to test the apparent association. Dyspnea, lacrimation and histopathological changes in the spleen and kidney were common findings in these studies. Mice showed a mild decrease in immune response when injected (route not specified) with a single dose of 2. These studies reported congested, swollen or necrotic kidneys, clinical signs of kidney disease or lethality (10 mg/kg for 7-11 days in dogs). Endpoints evaluated included body weight, weights of major organs, histopathology of major organs, hematology and clinical chemistry. The most sensitive endpoint was a marked increase in lactate dehydrogenase in urine of dogs dosed orally with 5 mg/kg-day for an unspecified period at levels that did not result in clinical signs of kidney toxicity. Nephrotoxic effects were reported in rabbits receiving 20 mg/kg-day iv for 8 weeks, pigs dosed orally for 70 days with 20 mg/kg-day and rats dosed orally with 14 mg/kg-day for 15 days. These studies indicate that key targets of citrinin toxicity are the kidney and potentially the immune system. Additional data from repeated dose studies are summarized in the context of the carcinogenicity data. Ten pregnant females from each of these groups were fed 0, 1, 3 or 5 ppm citrinin in the diet until day 20 of pregnancy. Maternal endpoints included: number of corpora lutea, number of implants, resorptions and live and dead fetuses. Dams in all treatment groups showed clinical signs prior to mating, such as increased water intake and polyuria, and rough hair coat; there was no mortality; clinical signs (further details not reported) were also seen in the 114 pregnant animals. While maternal body weight for the all treatment groups was significantly different from control at day 0 (indicating pre-pregnancy toxicity from the exposure 10 weeks prior to mating) and throughout gestation, the percentage increase in body weight gain during pregnancy was similar. At 3 and 5 ppm, the number of resorptions, resorptions as percent of implants, and post implantation loss were increased, whereas fetal weight and crown-rump length were decreased relative to controls. At 5 ppm, the percent of live fetuses was decreased, and gross anomalies, and skeletal and visceral malformations were increased (enlarged renal pelvis, hydrocephaly, microphthalmia, incomplete ossification of skull bones) when compared with controls. Mild to moderate maternal toxicity (degenerative liver changes, renal lesions, reduced weight gain and feed intake, polydypsia and polyuria) was reported. Embryo/fetal effects included retarded growth, increased fetal resorption rate, and severe malformations (hydrocephalus, cleft palate), in addition to evidence of systemic toxicity (enlarged kidneys, renal tubular necrosis and degeneration). Compromised body weight gain was seen in one study and maternal lethality in both studies. Live fetuses and fetal weight were reduced and minor fetal anomalies occurred in one of the studies. An oral one-generation study in rats investigated only oxidative stress and apoptosis in the liver, kidney and testes, not functional or histopathology indicators of reproductive endpoints (Singh et al. Apoptosis and 115 oxidative stress was noted in the liver, kidney and testes of both generations. Overall, a number of studies in mice and rats using both oral and parenteral dosing reported developmental toxicity, including malformations. The mechanistic evidence (oxidative stress) and results from parenteral dosing also indicate that citrinin causes male reproductive toxicity, but information is lacking on standard endpoints following exposure via an environmentally relevant route. Citrinin causes chromosome damage in vivo (micronuclei) and in vitro in a variety of animal cell models and in human lymphocytes. Animals were weighed weekly and control (5-10) and experimental animals (8-17) were sacrificed at weeks 32, 40, 60 and 80 weeks. Kidney, liver, lung and spleen were examined histopathologically; kidneys were also examined ultrastructurally. Throughout the experiment, citrinin-fed animals showed decreased body weight relative to controls. At each time point, mean kidney weight and relative kidney weight were increased in the treatment group. At week 32, the kidneys of treated animals (13/13) showed focal hyperplasia, marked proximal tubular dilatation, and interstitial fibrosis. Renal adenoma incidence in treated rats at 32, 40, 60, 80 weeks were as follows: 0/13, 8/8, 17/17, 10/10. Mice (20/group) fed diets of 0, 100 or 200 ppm citrinin for 70 weeks showed no differences in survival and did not develop renal tumors. Although this assessment is almost 30 years old, no additional data are available to modify this conclusion. Decreased implantation rates, and reduction in oocyte maturation rate, fertilization and embryonic development were found in mouse blastocysts and embryoblasts showing increased apoptosis. In a review, Doi and Uetsuka (2014) summarized in vitro and in vivo reports indicating that citrinin causes oxidative stress that leads to apoptosis, most notably in mouse skin. Summary of Toxicity Data for Citrinin Study Type Toxicokinetics Route, Duration 1 sc in pregnant rats, 1 iv study in rats, 1 oral study in pigs, 1 in vitro study with human skin References Boonen et al. Studies in multiple mammalian species by oral, dietary, intravenous, subcutaneous and intraperitoneal routes for durations ranging from acute to chronic have shown renal tubular dilatation, nephrosis, necrosis and (in one case) tumors. Adverse effects have also been reported in the liver at high doses, but no liver effects were reported in the key repeated dose studies (Arai and Hibino, 1983; Lee et al. Several studies have reported effects on the immune system, but the data are inconsistent regarding the nature and direction. However, the data are insufficient to determine whether citrinin is a direct developmental toxicant, since all developmental toxicity either occurred above doses that caused effects in the dams, or occurred in the presence of severe maternal toxicity (lethality). No standard studies were located that investigated reproductive effects or histopathology of the reproductive organs following dosing via an environmentally relevant route.

The total number of tubercle bacilli decreases back spasms 32 weeks pregnant mefenamic 250mg mastercard, and in a few cases they disappear muscle relaxant ibuprofen buy mefenamic 250mg on-line, at least temporarily spasms after gallbladder surgery buy generic mefenamic 250mg on line. Pyuria diminishes muscle relaxant ibuprofen cheap mefenamic 250 mg on-line, and there is an increase in the capacity of the bladder and a decrease in the frequency of urination. So far, the results of treatment have not been of a permanent character, but appear to be palliative. Too few cases have been studied to make any statements concerning the final results, but outstanding improvement has occurred in some of the cases reported after treatment for sixty to ninety days. In summing up, then, it can be said that streptomycin has a powerful effect on the tubercle bacillus, and that this effect is reflected in the results observed in certain forms of clinical tuberculosis. This drug should be reserved for patients with a poor prognosis and for those who have an advancing lesion in spite of the usual medical treatment. In this way the number of reactions are reduced and the number of strains of tubercle bacilli that become resistant is likewise reduced. Studies now in progress in various institutions in the United States should give additional information that will guide the medical profession in the future use of streptomycin. Zintel and his associates at the University Hospital in Philadelphia have shown that the oral administration of streptomycin reduces the total population of bacteria in the feces. A greater number of such resections can be done with primary suture, and the chances of peritoneal infection are reduced, if streptomycin is employed in this way. Antibacterial A g e n t s f r o m Microbes I n selecting the topic of antibacterial agents from microbes, I want to sketch for you the origin of some of our most potent anti-infectious agents thus derived. I propose introducing the subject by telling you something about the history of the discovery and the cause of anthrax. Man acquires infection from coming in contact with infected material, such as hides, wool, horse hair, shaving brushes. The spores have been shown to be present in the tusks of elephants and have occasionally been transmitted to man in the manufacture of the ivory tips for piano keys. I shall begin my story by telling you that in 1 8 7 6, a young practitioner of medicine in Wollstein, East Prussia, proved that the small sporulating rods found in the blood of animals dying of anthrax are the cause of the disease. The name of the practitioner was Robert Koch, who later discovered the bacteria causing tuberculosis. Organisms had been seen in the blood of animals dying of anthrax by others before Koch, but their significance was questioned. In fact, when Koch announced his discovery there was still doubt in the minds of some of the French scientists concerning their significance, because they had been unable to find the organisms in the blood of all animals dying of anthrax. Moreover, Paul Bert, the great pupil of Claude Bernard, insisted that the disease was due to a virus, since he could expose the blood containing bacilli to high concentrations of oxygen and destroy the bacilli and still produce the disease in experimental animals. He isolated the anthrax bacillus and cultured it through many generations until he felt that the organism was free of any contamination or virus. It remained, however, for him to explain the observations of Julliard and Leplat that not all animals dying of anthrax had this bacillus in their blood. There he found a cow dead of anthrax sixteen hours, a sheep and a horse dead of the same disease for thirty hours. The blood from the sheep and the horse contained putrefactive organisms but no anthrax bacilli. Inoculation of animals with this blood caused death from sepsis but not from anthrax. By cultural methods Pasteur succeeded in separating the aerobic anthrax bacilli from the anaerobic putrefactive organisms responsible for the deaths from sepsis. One day while transferring anthrax bacilli from one flask to another, the media being boiled urine, the culture became contaminated with some air organisms. T o his surprise and consternation, he found that anthrax bacilli had disappeared. He drew the logical conclusion that the contaminating organisms were responsible for their death. He went further and showed that several different organisms were capable of killing anthrax bacilli. A few attempts were made to show the antagonistic effect of some organisms upon anthrax by injecting guinea pigs with mixed cultures. Here, then, was further proof that the products of the growth of one bacterium killed another. These observations created great excitement, and for some time there was considerable interest in the question of bacterial antagonism. Metchnikoff noted that the lactobacilli in the stools decreased sharply or disappeared altogether during an attack of dysentery. He suggested that it might be possible to reverse the situation-that is, by increasing the numbers of lactobacilli, the pathogenic bacteria might be killed off. There followed a great many observations concerning the phenomena of bacterial antagonism. Many reports were made, and, naturally, there were attempts to apply the rapidly developing theory of bacterial antagonism to medical therapeutics. A number of bacteria were found to be antagonistic to anthrax bacillus, including B. But attempts to use pathogenic bacteria to destroy other organisms were not highly successful in the treatment of human infections. New light was shed on this problem in 1904 when Frost found that under certain conditions, typhoid bacilli were destroyed within a few days after they were added to soil. However, under conditions that were unfavorable to the growth of soil bacteria, the typhoid bacilli could persist for months. These observations led Frost to conclude that when the soil bacteria were given the opportunity to grow and to develop by-products then they could kill the typhoid bacillus. In other words, it was the metabolic products of the bacteria that killed the organisms and not a lack of food for both organisms that caused the death of one. Here was a startling discovery, and commercial preparations began to appear on the market which for eight or nine years were used to a considerable extent in the treatment of a wide variety of infections. Unfortunately, the results were inconsistent and irregular, so that pyocyanase was finally given up as a therapeutic agent. It is perhaps well to pause at this point in our narrative and inquire into the causes for the irregularity in the action of pyocyanase. Finally, it has been ascertained that these substances are toxic when given parenterally, so that they are of no use parenterally. Following this period of excitement over the possible use of antibacterial agents derived from microbes for medical therapeutics there was a lag period in which attention was turned to other agents, such as antitoxins, bacterophage, and antiserums. Once the coating of sugar had been removed from the pneumococcus and digested, the body of the pneumococcus could be devoured by the leucocytes of the body with the greatest of ease. For several years, Dubos had been interested in the problems of cellulose decomposing bacteria of the soil. Each year a large quantity of leaves, stalks, and other cellulose material falls on every acre of forest land in the United States, and each year a large quantity of this cellulose is digested by organisms in the soil. Without the activity of these organisms, plants and trees would be deprived of food. It occurred to Dubos that it might be possible to find a microbe that could use the vinegar of the pneumococcus for food or at least to train an organism to digest the pneumococcus carbohydrate as a source of nourishment. Since there is usually adequate space and food, organisms live alongside one another for years without lapsing into a destructive state in their struggle for survival and existence. But Dubos asked the question, What would happen to soil microbes if they were starved or if their food supply was greatly reduced? Could organisms that were starving adapt themselves to a new and strange diet and save themselves? Therefore, he gathered samples of soil and placed them in containers carefully protected from the air. With the passage of time, as the food supply of the bacteria was used up, the organisms began to weaken. Many of the organisms were unable to use this sugar as a source of food, but in the containers filled with peat from a N e w Jersey cranberry bog were some microbes that survived. Dubos grew them in many generations until they were accustomed to the carbohydrate diet. H e then isolated from these bacteria the enzyme that was capable of digesting the carbohydrate.

purchase mefenamic 250mg on line

Amiodarone should be used only if the arrhythmia cannot be controlled with other agents muscle relaxant bruxism buy mefenamic 250mg without prescription. Electrical cardioversion is in general not recommended due to recurrence of tachycardia spasms jerks discount 500mg mefenamic free shipping. Catheter ablation should be considered in drug-resistant and poorly tolerated cases muscle relaxant 250 mg mefenamic amex. A rapid ventricular response to these arrhythmias can lead to serious haemodynamic consequences for both the mother and the fetus spasms 1983 dvd order 500mg mefenamic amex. Diagnosis and treatment of the underlying condition are therefore the first priorities. Electrical cardioversion should be performed in the case of haemodynamic instability. Amiodarone is not recommended, unless other options fail, due to its fetotoxic effects. Indications for prophylactic antiarrhythmic drugs and anticoagulation relate to the presence of symptoms and the presence of risk factors for thrombo-embolism, respectively. In these, a benefit of oral anticoagulation is documented when the thrombo-embolic risk is 4. Therefore, also in pregnant patients, thromboprophylaxis is recommended in high risk patients. Vitamin K antagonists are recommended in most cases from the second trimester until 1 month before expected delivery. The new oral thrombin antagonists such as dabigatran have shown fetotoxicity with high doses and should not be used. Either single or dual antiplatelet therapy (clopidogrel and acetylsalicylic acid) were not as effective as warfarin in high risk patients with atrial fibrillation. Subcutaneous administration of weight-adjusted therapeutic doses is recommended during the first trimester and during the last month of pregnancy. Prophylactic antiarrhythmic drugs (sotalol, flecainide, or propafenone) may be considered in the case of severe symptoms despite rate-controlling drugs. The presence of inherited arrhythmogenic disorders should always be considered by family history and appropriate diagnostic tests during or after pregnancy. Prophylactic therapy with a cardioselective b-blocking agent, such as metoprolol, may be effective. Rare cases of sinus bradycardia have been attributed to the supine hypotensive syndrome of pregnancy, caused by uterine compression of the inferior vena cava blood return with paradoxical sinus slowing. In the rare instance that symptomatic bradycardia occurs, it should be managed by changing the position of the mother to a left lateral decubitus position. Due to the high radiation exposure, ablation should be postponed to the second trimester if possible, and it should be performed at an experienced ablation centre with suitable lead shielding and maximal use of echo- and electro-anatomic mapping systems. Fetal radiation dose and risk from catheter ablation procedures during pregnancy have been calculated25 (see Section 2. The majority of cases are second-degree type I Wenckebach block, unassociated with symptomatic bradycardias. Acquired complete heart block, most often seen in congenital heart disease after corrective surgery, is rare during pregnancy. Vaginal delivery carries no extra risks in a mother with congenital complete heart block, unless contraindicated for obstetric reasons. The risks of permanent pacemaker implantation (preferably one chamber) are generally low. Implantation can be performed safely, especially if the fetus is beyond 8 weeks gestation. Immediate electrical cardioversion is recommended for acute treatment of any tachycardia with haemodynamic instability. Catheter ablation may be considered in the case of drug-refractory and poorly tolerated tachycardias. For drug dosing information, please refer to three published guidelines on the management of patients with atrial fibrillation, supraventricular arrhythmias, and ventricular arrhythmias. Hypertensive disorders Hypertensive disorders in pregnancy remain a major cause of maternal, fetal, and neonatal morbidity and mortality in developing and in developed countries. These women are at higher risk for severe complications such as abruptio placentae, cerebrovascular accident, organ failure, and disseminated intravascular coagulation. The fetus is at risk for intrauterine growth retardation, prematurity, and intrauterine death. Hypertension is the most common medical problem in pregnancy, complicating up to 15% of pregnancies and accounting for about a quarter of all antenatal admissions. Pre-eclampsia is a pregnancy-specific syndrome that occurs after mid-gestation, defined by the de novo appearance of hypertension, accompanied by new-onset of significant proteinuria. Oedema is no longer considered part of the diagnostic criteria, as it occurs in up to 60% of normal pregnancies. Overall, pre-eclampsia complicates 5­7% of pregnancies,213 but increases to 25% in women with pre-existing hypertension. Pre-eclampsia occurs more frequently during the first pregnancy, in multiple fetuses, hydatidiform mole, or diabetes. It is associated with placental insufficiency, often resulting in fetal growth restriction. Additionally, pre-eclampsia is one of the most common causes of prematurity, accounting for 25% of all infants with very low birth weight (,1500 g). Management of pre-eclampsia focuses essentially on recognition of the condition and, ultimately, delivery of the placenta, which is curative. As proteinuria may be a late manifestation of pre-eclampsia, it should be suspected when de novo hypertension is accompanied by headache, visual disturbances, abdominal pain, or abnormal laboratory tests, specifically low platelet count and abnormal liver enzymes; it is recommended to treat such patients as having pre-eclampsia. Ultrasound investigation of the adrenals and urine metanephrine and normetanephrine assays may be considered in pregnant women with hypertension to exclude pheochromocytoma which may be asymptomatic and, if not diagnosed before labour, fatal. This may mask the pre-existing hypertension and, when hypertension is recorded later in pregnancy, it may be interpreted as gestational. Women with essential hypertension and normal renal function have good maternal and neonatal outcomes and are candidates for non-drug therapy because there is no evidence that pharmacological treatment results in improved neonatal outcome. However, close monitoring and, if necessary, resumption of treatment is necessary. The only trial of treatment of hypertension in pregnancy with adequate infant follow-up (7. A short-term hospital stay may be required for confirming the diagnosis of and ruling out severe gestational hypertension (pre-eclampsia), in which the only effective treatment is delivery. A normal diet without salt restriction is advised, particularly close to delivery, as salt restriction may induce low intravascular volume. Calcium supplementation of at least 1 g daily during pregnancy almost halved the risk of pre-eclampsia without causing any harm. Fish oil supplementation218 as well as vitamin and nutrient supplements have no role in the prevention of hypertensive disorders. Low dose acetylsalicylic acid (75 ­100 mg/day) is used prophylactically in women with a history of early-onset (,28 weeks) pre-eclampsia. Weight reduction is not recommended during pregnancy in obese women, because it can lead to reduced neonatal weight and slower subsequent growth in infants of dieting obese mothers. However, as maternal obesity can result in negative outcomes for both women and fetuses, guidelines for healthy ranges of weight gain in pregnancy have been established. If taken inadvertently during the first trimester, switching to another medication and close monitoring including fetal ultrasound are advisable and usually are sufficient. Potential synergism with magnesium sulfate may induce maternal hypotension and fetal hypoxia. Diuretics should be avoided for treatment of hypertension because they may decrease blood flow in the placenta. The selection of the antihypertensive drug and its route of administration depend on the expected time of delivery. Prolonged treatment with sodium nitroprusside is associated with an increased risk of fetal cyanide poisoning as nitroprusside is 9. Delivery Induction of delivery is indicated in gestational hypertension with proteinuria with adverse conditions such as visual disturbances, coagulation abnormalities, or fetal distress. Most of the antihypertensive drugs are present at very low concentrations, except for propranolol and nifedipine, whose concentrations in breast milk are similar to those in maternal plasma.

purchase mefenamic 250mg amex

In general muscle relaxer 86 67 buy 250mg mefenamic otc, patients with severe with drawal may receive 20mg of diazepam or 100mg of chlordiazepoxide every 2 to 3 hours until improvement or sedation prevails muscle relaxant 10mg discount mefenamic 500 mg overnight delivery. Oversedation muscle spasms zoloft purchase mefenamic 500mg fast delivery, ataxia (lack of muscular coordi nation) spasms quadriplegic order mefenamic 250 mg amex, and confusion, particularly in elderly patients, may occur with this protocol. The treatment staff should closely monitor hemody namic (blood pressure and pulse) and respira tory features. They should particularly be pre pared to detect and rapidly treat apnea (no breathing) with assisted ventilation. Having experienced staff with adequate time to fre quently monitor the patient and provide intra venous medication is necessary. Benzodiazepine treatment of alcohol withdrawal Depending upon the clinical setting and the patient circumstances, there are several accept able regimens for treating alcohol withdrawal that make use of benzodiazepines. These drugs remain the medication class of choice for treat ing alcohol withdrawal. The early recognition of alcohol withdrawal and prompt administra tion of a suitable benzodiazepine usually will prevent the withdrawal reaction from proceed ing to serious consequences. Patients suspected of alcohol withdrawal should be seen promptly by a primary care provider (physician, nurse practitioner, physician assistant) who has expe rience in diagnosing and managing alcohol withdrawal. This regimen has been used successfully with short, intermediate, and long halflife benzodi azepines. Dosage amount and frequency can be modified depending on the individual clinical situation as determined by the medical provider. Patients with a history of withdrawal seizures should receive scheduled doses of a longact ing benzodiazepine. It must be noted here that symptom triggered therapy is not recommended for outpatient detoxification. Symptomtriggered therapy requires monitoring and decision making by a healthcare professional. An alternative regimen might be the administration of 1 to 2mg lorazepam two or three times a day the first day, followed by gradual reduction over the next 3 to 5 days. The general approach to tapering is to estab lish an acute dose in the first 24 hours, then to reduce it over the next three days: for example, 400 chlordiazepoxide total on day 1, then 300, 200, 100, and off on day 5. Doses of withdrawal Benzodiazepines medication are omit ted if the patient is remain the sleeping soundly, showing signs of medication class oversedation, or exhibiting marked of choice for ataxia. Gradual, tapering doses Before beginning any tapering regimen, the patient must be fully stabilized; that is, all signs and symptoms of withdrawal must be improved. Once the patient has been stabilized, oral benzodiazepines can be administered on a predetermined dosing schedule for several days and gradually tapered over time. Dosing protocols vary widely among treat ment facilities based on the needs of the patient population. One example is that patients might receive 50mg of chlordiazepox ide or 10mg of diazepam every 6 hours during the first day of treatment and 25mg of chlor diazepoxide or 5mg of diazepam every 6 hours on the second and third days. This approach to dosing, that is, every 6 hours, is not as accurate in tailoring medications to counter symptoms; a more precise dosing reg imen is titrating (adjusting dosage in light of treating alcohol the use of gradual, tapering doses is appealing in settings withdrawal. Under or overmedication with this regimen can occur depending on benzodiazepine toler ance; the presence of chronic cigarette smok ing, which induces benzodiazepine metabolism; liver function; age; and the pres ence of cooccurring medical or psychiatric conditions. The use of this regimen may be problematic in the outpatient settings in which it frequently is applied. Supplying the patient with 4 to 5 days of a benzodiazepine and facing the probability that the patient may drink and take the benzodiazepine is a hazard. It is important to enforce strict limi tations on driving automobiles, climbing, or operating hazardous machinery. Physical Detoxification Services for Withdrawal From Specific Substances 59 Single daily dosing protocol Jauhar and Anderson (2000) compared single daily dosing of diazepam to multiple daily dos ing of chlordiazepoxide in inpatients being treated for alcohol withdrawal. Patients in the diazepam single daily dose group did as well as the chlordiazepoxide multiple dosing group. The authors suggest that this regimen might be attractive in community or social detoxification settings, particularly if patients could be moni tored between administered doses. The choice of the specific benzodiazepine for any particular regimen depends on a number of factors, but the most significant factor is that the clinician administer one that she has the most experience using. Despite 30 years of research, no single benzodiazepine has emerged as the number one drug of choice in treating alcohol withdrawal. All benzodiazepines stud ied have worked better than placebo but have been roughly equivalent with each other. Many clinicians prefer long halflife benzodiazepines such as chlordiazepoxide and diazepam, desir ing less frequent daily dosing, relatively steady serum levels, and the ability of these drugs to selftaper based on their long halflives. Lorazepam Lorazepam (Ativan) has an intermediate half life of about 8­15 hours, and although it usual ly is administered in multiple doses each day, it can be given approximately twice per day. Lorazepam, with its shorter halflife and lack of storage in adipose (fatty) tissue, actually has to be given more frequently than the longact ing preparations, not less. However, it has been suggested that seizures may occur late in detoxification with shortact ing benzodiazepines such as lorazepam and oxazepam (Shaw 1995). Oxazepam Oxazepam (Serax) often is favored by internists and hepatologists treating alcohol withdrawal in patients with severe liver failure. The agent is relatively limited in that its oral absorption is quite slow compared to other benzodiazepines, it must be given three to four times a day, and is only available in the United States in an oral form. Ultimately, the experience of the treating clini cian, characteristics of the patient, and the set ting in which he will be treated will determine the choice of drug. Although all benzodi azepines are now generic in the United States, costs vary and this too may be a factor in choice. Intramuscular use of these drugs is to be discouraged since muscle absorption is erratic. One study sug gests that if chlordiazepoxide (Librium) is taken in overdose with alcohol, it is less likely to be fatal than diazepam (Valium) (Serfaty and Masterton 1993). Detractors of the use of these two drugs point out that they have long halflives (although some clinicians see this as an advantage because it prevents the emer gence of withdrawal symptoms between doses), have multiple active metabolites, and go through many oxidative metabolic steps in the liver. Older patients or patients with liver dis ease are likely to accumulate these medications quickly without being able to metabolize them. Possible consequences include oversedation or Limitations of benzodiazepines in outpatient treatment Although benzodiazepines remain the mainstay of treatment for alcohol withdrawal, they have limitations that are particularly pronounced when treating outpatients. Abuse usually is in the context of the concur rent use of alcohol, opioids, or stimulants. There are two other limitations of benzodi azepines that may be relevant in some clinical settings for some patients. First, although ben zodiazepines have been studied for more than 30 years and are effective for suppressing alco hol withdrawal symptoms at any one episode, their ability to halt the progressive worsening of each successive alcohol withdrawal reaction is in question. There are now at least nine stud ies that have found that an everincreasing number of previous alcohol withdrawals increases the severity of withdrawal, particu larly seizures and delirium tremens, and decreases responsiveness to benzodiazepines (Ballenger and Post 1978; Booth and Blow 1993; Brown et al. However, within this group of one in five indi viduals, seizures were three times more com mon than in the larger, nonprogressive group and premature age of death was 7 years younger than for the nonprogressive group. In the majority of these studies, patients were treated with benzodiazepines, although in a few, phenobarbital was used. A second, and at present more hypothetical, concern about benzodiazepine use to treat out patients in alcohol withdrawal is that they may "prime" or reinstate alcohol use during their administration. Two preclinical studies support this premise (Deutsch and Walton 1977; Hedlund and Wahlstrom 1998). A recent ran domized, blinded, clinical trial comparing car bamazepine to lorazepam for the outpatient treatment of alcohol withdrawal found that the outpatients on lorazepam were three times as likely to drink as those on carbamazepine. The lorazepam group drank about twice as much alcohol in the immediate postdetoxification period than the carbamazepine group (Malcolm et al. For a list of potential contraindications to using benzodiazepines to treat alcohol withdrawal in certain patients, see Figure 43. Other medications Barbiturates Barbiturates have been used for nearly a cen tury for the treatment of alcohol withdrawal. Most barbiturates, other than phenobarbital, have fallen into disfavor because of severe Figure 43 Potential Contraindications To Using Benzodiazepines To Treat Alcohol Withdrawal · Previous allergic reaction · Previous paradoxical disinhibition. Physical Detoxification Services for Withdrawal From Specific Substances 61 lethal interactions with alcohol, death Delirium and from overdose of the agents alone, rapid seizures are the tolerance, and high abuse potential. In pathological clinical practice, the medication is effec tive both for the responses seen in treatment of alcohol withdrawal and alcohol sedativehypnotic withdrawal although withdrawal. Members of the consensus panel recommend its use only in highly supervised settings. Other agents Beta blockers and alpha adrenergic agonists such as clonidine have been used in the treat ment of alcohol withdrawal.

Cheap 250 mg mefenamic with amex. Cyclobenzaprine (Flexeril): Dosage & Side Effects..

References

  • Bradley LA, Kersh BC, DeBerry JJ, et al. Lessons from fibromyalgia: abnormal pain sensitivity in knee osteoarthritis. Novartis Found Symp 2004; 260:258-70.
  • Oliveira L, Wexner SD, Daniel N, et al: Mechanical bowel preparation for elective colorectal surgery, Dis Colon Rectum 40:585n591, 1997.
  • Baeriswyl V, Christofori G. The angiogenic switch in carcinogenesis. Semin Cancer Biol 2009;19(5):329-337.
  • Newsome BB, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168(6):609.
Download Common Grant Application and Other Forms
Wind Engine Restoration Project
Grant Deadlines